NEW YORK (GenomeWeb News) – Scientists at Brigham and Women's Hospital and Children's Hospital Boston will use a $4.2 million grant from the National Heart, Lung, and Blood Institute to identify genetic and epigenetic causes of congenital heart disease.

Funded through the NHLBI's Pediatric Cardiac Genomics Consortium, the researchers will relate genetic variants found in patients with congenital heart disease to clinical outcomes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.